Investor insights
Sectors invested in
Funding rounds participated in
$82M sweet spot round size
Most of their 18 investments are in rounds between $50M and $148M
Investor type
Basic info
Industry
Sectors
Date founded
2015
Investments made
Aktis Oncology raised $84M on August 25, 2022
Investors: Octagon Capital Advisors, Pappas Capital, TCG X, MPM Capital, Merck Group, Vida Ventures, LLC and NS Investment
Aspen Neuroscience, Inc. raised $148M on May 9, 2022
Investors: LYFE Capital, Newton Investment Management, Lifeforce Capital, OrbiMed Advisors, GV, Medical Excellence Capital, LLC, Section 32, Revelation Partners and NS Investment
Undisclosed raised $4M on March 28, 2022
Investors: Company K Partners, AJU IB INVESTMENT, Paratus Investment Inc. and NS Investment
Dewpoint Therapeutics raised $150M on February 3, 2022
Investors: Samsara BioCapital, Polaris Partners, Maverick Ventures, Leaps by Bayer, General Catalyst, SoftBank Investment Advisers and NS Investment
Maze Therapeutics raised $190M on January 10, 2022
Investors: General Catalyst, Casdin Capital, LLC, Foresite Capital, City Hill Ventures, Driehaus Capital Management LLC, Woodline Partners LP and NS Investment
Shoreline Biosciences, Inc. raised $140M on November 2, 2021
Investors: Kingdon Capital Management, Wedbush Securities, Irving Investors, Stork Capital S.à.r.l., -, Eventide Asset Management, Piper Sandler and NS Investment
ReCode Therapeutics raised $210M on October 21, 2021
Investors: Sanofi Ventures, -, OrbiMed Advisors, Vida Ventures, LLC, Tekla Capital Management, Osage University Partners (OUP), MPM Capital and NS Investment
Immunitas Therapeutics raised $58M on August 18, 2021
Investors: M Ventures, The Leukemia & Lymphoma Society, Solasta Ventures, Mirae Asset MAPS Global Investments Co., Ltd, Longwood Fund, Medical Excellence Capital, LLC and NS Investment
Sonoma Biotherapeutics raised $265M on August 4, 2021
Investors: Lilly Asia Ventures, Octagon Capital, Piper Sandler, JDRF T1D Fund, Osage University Partners (OUP), Lifeforce Capital, Mirae Asset MAPS Global Investments Co., Ltd, Vertex Ventures HC and NS Investment
Silverback Therapeutics raised $79M on March 11, 2020
Investors: Nextech Invest, Hunt Investment Co, OrbiMed Advisors, Pontifax Venture Capital, Bristol-Myers Squibb, UK and NS Investment